Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Medical Marijuana Inc    MJNA

MEDICAL MARIJUANA INC (MJNA)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
The feature you requested does not exist. However, we suggest the following feature:

Medical Marijuana, Inc. : Applauds New Market Opportunities for CBD, U.S. Farmers as Sen. Mitch McConnell Pushes Bill to Legalize Hemp

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/13/2018 | 03:01pm CEST

SAN DIEGO, April 13, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that the Company applauds U.S. Senate Majority Leader Mitch McConnell's first public announcement of his intention to remove industrial hemp from the Controlled Substances Act with the introduction of the Hemp Farming Act of 2018.

Previously, McConnell helped develop new federal and state legal permissions for hemp and even steered hemp into the 2014 Farm Bill. Now, according to McConnell's public senate announcement on Thursday, April 12, the Hemp Farming Act of 2018 would remove hemp with less than 0.3 percent of tetrahydrocannabinol (THC) from the controlled substances list. This would include the de-scheduling of all derivatives, extracts and seeds of hemp as long as those portions of the plant remain below the THC requirement.

"During the recent state work period, I talked to a number of farmers, manufacturers, and small business owners who expressed enthusiasm for hemp's potential, and I was proud to stand with Kentucky's Agriculture Commissioner Ryan Quarles to announce the impending introduction of this bill," said Senate Majority Leader Mitch McConnell in his senate speech.

The bill would also add hemp as an eligible commodity for the purposes of crop insurance. This allows farmers to access capital for cultivation and production of hemp and hemp products. For hemp research and production, the Hemp Farming Act of 2018 would make hemp research eligible for competitive grant funding under the National Agricultural Research, Extension, and Teaching Policy Act of 1977.

"This bill has such widespread bipartisan support that it is not only being considered to be an amendment to the Farm Bill of 2018, but also a unique bill on its own," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "It will take a lot of hard work to make hemp federally legal in the U.S., but we're happy to have someone of such power and influence working to help make this possible."

Medical Marijuana, Inc. currently produces its full spectrum hemp oil from industrial hemp grown in Europe. If made into law, this new bill could not only generate a major market opportunity for U.S. farmers to potentially source CBD oil for such products from U.S.-based hemp crops, but it could make hemp cultivation legal federally as well, making CBD oil more affordable and accessible for those in need.

Medical Marijuana, Inc. subsidiary HempMeds®, the company that sells the company's Real Scientific Hemp Oil™ CBD hemp oil, was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 and was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 858-264-6600
[email protected]
www.cmwmedia.com

 

Cision View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-applauds-new-market-opportunities-for-cbd-us-farmers-as-sen-mitch-mcconnell-pushes-bill-to-legalize-hemp-300629422.html

SOURCE Medical Marijuana, Inc.


© PRNewswire 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDICAL MARIJUANA INC
04/13MEDICAL MARIJUANA, INC. : Applauds New Market Opportunities for CBD, U.S. Farmer..
PR
03/14MEDICAL MARIJUANA, INC. : Subsidiary HempMeds® Brazil and ANUC Host First-Ever H..
PR
03/05MEDICAL MARIJUANA, INC. : Subsidiary HempMeds® Announces Participation at First-..
PR
03/01MEDICAL MARIJUANA : Major Investment AXIM Biotech Announces First-Ever Successfu..
AQ
02/28MEDICAL MARIJUANA, INC. : Major Investment AXIM Biotech Announces First-Ever Suc..
PR
02/20MEDICAL MARIJUANA : Top 20 Business Site TheStreet.com Features Medical Marijuan..
PR
02/08Hemp Provides Investors Access to Larger Cannabidiol Market
AQ
02/05MEDICAL MARIJUANA, INC. : Subsidiary HempMeds® Garners National News Coverage in..
PR
01/31MEDICAL MARIJUANA, INC. : Subsidiary Phyto Animal Health Names Ian Quinn as CEO
PR
01/25MEDICAL MARIJUANA, INC. : Subsidiary Kannaway® Announces Exclusive Roadshow Even..
PR
More news
News from SeekingAlpha
06/08Canada Senate backs recreational use of marijuana 
06/07Canada poised to approve marijuana sales 
05/29Largest U.S. cannabis company listed on Canadian exchange 
05/25M&A in pot players should be considerable - Eight Capital 
05/25Punters betting on fall in pot stocks, short balances up to $2.1B 
Chart MEDICAL MARIJUANA INC
Duration : Period :
Medical Marijuana Inc Technical Analysis Chart | MJNA | US58463A1051 | 4-Traders
Managers
NameTitle
Stuart W. Titus Chairman, President, Chief Executive Officer & CFO
Blake N. Schroeder Chief Operating Officer & Executive Vice President
Michelle L. Sides Director
Robert L. Cunningham Independent Director
Chris Prine Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDICAL MARIJUANA INC-30.53%0
WORLDPAY INC7.04%26 692
CINTAS CORPORATION22.26%20 331
UNITED RENTALS-6.43%13 447
INTERTEK GROUP11.48%12 396
BUREAU VERITAS1.84%11 909